Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
StoneX Group Inc. Reports Fiscal 2024 First Quarter Financial Results
-
Cingulate Announces Closing of $7.5 Million Public Offering
-
Midland States Bancorp, Inc. Increases Common Stock Cash Dividend to $0.31 Per Share and Declares Preferred Stock Dividend
-
Highwoods Announces Availability of Fourth Quarter and Full Year 2023 Results
-
Enact Reports Fourth Quarter and Full Year 2023 Results
-
Apollo Commercial Real Estate Finance, Inc. Reports Fourth Quarter 2023 Results
-
DHT Holdings, Inc. Fourth Quarter 2023 Results
-
Arbor Realty Trust Schedules Fourth Quarter 2023 Earnings Conference Call
-
Evolution Petroleum Reports Second Quarter Fiscal 2024 Results and Declares Quarterly Cash Dividend for the Fiscal 2024 Third Quarter
-
H&R Block Reports Fiscal 2024 Second Quarter Results; Full Year Outlook Reaffirmed
-
GAMCO Investors, Inc. Reports Results for the Fourth Quarter and Year Ended December 31, 2023
-
Array Technologies, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
-
Freshworks Reports Fourth Quarter and Full Year 2023 Results
-
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
-
Gencor Releases First Quarter Fiscal 2024 Results
-
Enphase Energy Reports Financial Results for the Fourth Quarter of 2023
-
H&R Block Chief Financial Officer Tony Bowen Announces Retirement
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Sutro Biopharma to Participate in Upcoming Investor Conferences
-
Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
-
Magnite Announces Closing of New Senior Secured Revolving Credit and Term Loan Facilities
-
InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2023
-
Safe Bulkers, Inc. Sets Date for the Fourth Quarter 2023 Results, Conference Call, and Webcast
-
Tenable Announces Fourth Quarter and Full Year 2023 Financial Results
-
Lesaka delivers improved profitability as it exceeds FY24 Q2 guidance
-
A-Mark Precious Metals Reports Fiscal Second Quarter 2024 Results
-
Confluence Opens up a Center of Excellence in Bangalore in Partnership with Aeries
-
Intapp Announces Second Quarter Fiscal Year 2024 Financial Results
-
Regeneron Announces Investor Conference Presentations
-
Farmer Brothers Names John Moore Chief Executive Officer
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Fortinet Reports Fourth Quarter and Full Year 2023 Financial Results
-
EverQuote to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
-
89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
ACM Research to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 28, 2024
-
Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024
-
Mondelēz International to Present at CAGNY Conference on February 20
-
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook
-
Prospect Capital Schedules Second Fiscal Quarter Earnings Release and Conference Call
-
Mercury Systems Reports Second Quarter Fiscal 2024 Results
-
Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
EMCORE to Present at the TD Cowen 45th Annual Aerospace & Defense Conference
-
Woodward Named to Forbes List of America’s Most Successful Mid-Cap Companies
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
Intermex to Release Fourth Quarter 2023 Earnings
-
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Fordham Gabelli School of Business Responsible Business Center and Net Impact Forge Transformative Collaboration

